Skip to content

PARALLAX HEALTH SCIENCES, INC.: 10-Q filed 2018-09-28

What PARALLAX HEALTH SCIENCES, INC. reported in its quarterly report filed 2018-09-28 (fiscal Q2 2018): 24 published measures, 63 facts as tagged in accession 0001388410-18-000067.

This filing

Form
10-Q (quarterly report)
Filed
2018-09-28
Fiscal period
fiscal Q2 2018
Accession
0001388410-18-000067 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All PARALLAX HEALTH SCIENCES, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2018-06-302,909,077USD
At 2017-12-313,340,475USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2018-06-3035,812,294USD
At 2017-12-3130,730,119USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2018-06-3039,277USD
At 2017-12-31183USD
At 2016-12-319,910USD

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2018-01-01 to 2018-06-30-593,945USD181
2017-01-01 to 2017-06-30-40,515USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2018-04-01 to 2018-06-304,869USD91
2018-01-01 to 2018-06-309,759USD181
2017-04-01 to 2017-06-3026,241USD91
2017-01-01 to 2017-06-3040,502USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2018-01-01 to 2018-06-30767,549USD181
2017-01-01 to 2017-06-30399,993USD181

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2018-04-01 to 2018-06-30146,211,165shares91
2018-01-01 to 2018-06-30144,700,905shares181
2017-04-01 to 2017-06-30111,422,546shares91
2017-01-01 to 2017-06-30109,358,489shares181

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2018-04-01 to 2018-06-30209,998,947shares91
2018-01-01 to 2018-06-30208,488,686shares181
2017-04-01 to 2017-06-30157,463,485shares91
2017-01-01 to 2017-06-30155,399,428shares181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2018-04-01 to 2018-06-30-1,307,611USD91
2018-01-01 to 2018-06-30-3,259,420USD181
2017-04-01 to 2017-06-30-468,413USD91
2017-01-01 to 2017-06-30-922,891USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2018-06-3045,237USD
At 2017-12-3155,419USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2018-06-306,199,243USD
At 2017-12-314,418,915USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2018-06-30951,700USD
At 2017-12-31865,569USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2018-06-30785,060USD
At 2017-12-31785,060USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2018-06-302,078,780USD
At 2017-12-312,298,094USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2018-06-30180USD
At 2017-12-313,275USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2018-04-01 to 2018-06-30130USD91
2018-01-01 to 2018-06-30-518USD181
2017-04-01 to 2017-06-30-14,470USD91
2017-01-01 to 2017-06-30-28,251USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2018-06-30147,661,711shares
At 2017-12-31136,754,530shares

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2018-06-30-32,903,217USD
At 2017-12-31-27,389,644USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2018-04-01 to 2018-06-30-3,780,047USD91
2018-01-01 to 2018-06-30-7,636,516USD181
2017-04-01 to 2017-06-30-2,827,012USD91
2017-01-01 to 2017-06-30-5,467,284USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2018-04-01 to 2018-06-301,307,741USD91
2018-01-01 to 2018-06-303,258,902USD181
2017-04-01 to 2017-06-30453,943USD91
2017-01-01 to 2017-06-30894,640USD181

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2018-01-01 to 2018-06-30-219,314USD181
2017-01-01 to 2017-06-30-75,470USD181

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2018-01-01 to 2018-06-30219,314USD181
2017-01-01 to 2017-06-3075,470USD181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2018-01-01 to 2018-06-3041,000USD181
2017-01-01 to 2017-06-301,500USD181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2018-01-01 to 2018-06-302,859USD181
2017-01-01 to 2017-06-30-4,492USD181

Inspect the source

Entity
PARALLAX HEALTH SCIENCES, INC. / CIK 0001388410
Captured
SEC response SHA-256
94ef7b5cf30837ee48a9b3f8b759fe12b3da087f5b0a8ff4d38505bc8677ecf0

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001388410.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))